heart

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

4 weeks ago

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

4 weeks ago

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

1 month ago

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

1 month ago

Experience “Sakura” – A Japanese Springtime Tradition: Tokyo Dome Hotel in the Heart of Viewing Spots!

Book now and receive up to 50% off during the peak of cherry blossom season TOKYO, Nov. 15, 2024 /PRNewswire/…

1 month ago

Experience “Sakura” – A Japanese Springtime Tradition: Tokyo Dome Hotel in the Heart of Viewing Spots!

Book now and receive up to 50% off during the peak of cherry blossom season TOKYO, Nov. 15, 2024 /PRNewswire/…

1 month ago

Experience “Sakura” – A Japanese Springtime Tradition: Tokyo Dome Hotel in the Heart of Viewing Spots!

Book now and receive up to 50% off during the peak of cherry blossom season TOKYO, Nov. 15, 2024 /PRNewswire/…

1 month ago

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from post-hoc…

1 month ago

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life New Data…

1 month ago

Experience “Sakura” – A Japanese Springtime Tradition: Tokyo Dome Hotel in the Heart of Viewing Spots!

Book now and receive up to 50% off during the peak of cherry blossom season TOKYO, Nov. 15, 2024 /PRNewswire/…

1 month ago